DocDollars

Alexion Pharmaceuticals, Inc.

MA · United States · Reporting entity ID 100000005462

Total reported 2019–2025
$182.4M
#61 of 2,960 reporting companies — 0.2% of all reported industry payments
$67.2M in general payments across 239,092 records, plus $115.2M in research funding across 9,380 records.

How it breaks down

General payments $67,224,221
Research funding $115,199,600

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Alexion Pharmaceuticals, Inc. reported $182.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #61 of 2,960 reporting companies. 63% of that was research funding and 37% general payments such as consulting, speaking, food and travel. 239,092 general payment records and 9,380 research records were filed.

Common questions about Alexion Pharmaceuticals, Inc.

How much has Alexion Pharmaceuticals, Inc. paid US doctors?

Alexion Pharmaceuticals, Inc. reported $182,423,821 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $67,224,221 in general payments, $115,199,600 in research funding.

How does Alexion Pharmaceuticals, Inc. rank among drug and device companies?

It ranks #61 of 2,960 reporting entities by total reported value, about 0.2% of all industry payments in the dataset.

Does a payment from Alexion Pharmaceuticals, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.